Literature DB >> 20056941

The role of microRNA-133 in cardiac hypertrophy uncovered.

Maha Abdellatif.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20056941      PMCID： PMC2838710          DOI： 10.1161/CIRCRESAHA.109.212183

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

1.  Fgf-dependent depletion of microRNA-133 promotes appendage regeneration in zebrafish.

Authors:  Viravuth P Yin; J Michael Thomson; Ryan Thummel; David R Hyde; Scott M Hammond; Kenneth D Poss
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

2.  The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes.

Authors:  Chaoqian Xu; Yanjie Lu; Zhenwei Pan; Wenfeng Chu; Xiaobin Luo; Huixian Lin; Jiening Xiao; Hongli Shan; Zhiguo Wang; Baofeng Yang
Journal:  J Cell Sci       Date:  2007-09-01       Impact factor: 5.285

3.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

4.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

5.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

6.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  MicroRNA-133 controls cardiac hypertrophy.

Authors:  Alessandra Carè; Daniele Catalucci; Federica Felicetti; Désirée Bonci; Antonio Addario; Paolo Gallo; Marie-Louise Bang; Patrizia Segnalini; Yusu Gu; Nancy D Dalton; Leonardo Elia; Michael V G Latronico; Morten Høydal; Camillo Autore; Matteo A Russo; Gerald W Dorn; Oyvind Ellingsen; Pilar Ruiz-Lozano; Kirk L Peterson; Carlo M Croce; Cesare Peschle; Gianluigi Condorelli
Journal:  Nat Med       Date:  2007-04-29       Impact factor: 53.440

8.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.

Authors:  Kathryn N Ivey; Alecia Muth; Joshua Arnold; Frank W King; Ru-Fang Yeh; Jason E Fish; Edward C Hsiao; Robert J Schwartz; Bruce R Conklin; Harold S Bernstein; Deepak Srivastava
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

9.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.

Authors:  Jiening Xiao; Xiaobin Luo; Huixian Lin; Ying Zhang; Yanjie Lu; Ning Wang; Yiqiang Zhang; Baofeng Yang; Zhiguo Wang
Journal:  J Biol Chem       Date:  2007-03-07       Impact factor: 5.157
View more
  21 in total

1.  RISC RNA sequencing for context-specific identification of in vivo microRNA targets.

Authors:  Scot J Matkovich; Derek J Van Booven; William H Eschenbacher; Gerald W Dorn
Journal:  Circ Res       Date:  2010-10-28       Impact factor: 17.367

Review 2.  MicroRNAs in heart development.

Authors:  Ramón A Espinoza-Lewis; Da-Zhi Wang
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

3.  Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.

Authors:  Alejandra Tapia-Castillo; Cristian A Carvajal; Jorge A Pérez; Carlos E Fardella
Journal:  Endocrine       Date:  2022-06-08       Impact factor: 3.925

Review 4.  MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications.

Authors:  Alina Ioana Scărlătescu; Miruna Mihaela Micheu; Nicoleta-Monica Popa-Fotea; Maria Dorobanțu
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 5.  The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac Remodelling.

Authors:  Michaela Adamcova; Ippei Kawano; Fedor Simko
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2011-06-30       Impact factor: 6.303

7.  MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.

Authors:  Huafu Zhao; Mei Li; Lihua Li; Xiaoming Yang; Guobo Lan; Yu Zhang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Plasma proANP and SDMA and microRNAs are associated with chronic mitral regurgitation in a pig model.

Authors:  Susanna Cirera; Sophia G Moesgaard; Nora E Zois; Nathja Ravn; Jens P Goetze; Signe E Cremer; Tom Teerlink; Páll S Leifsson; Jesper L Honge; J Michael Hasenkam; Lisbeth H Olsen
Journal:  Endocr Connect       Date:  2013-09-24       Impact factor: 3.335

9.  miRNA-133 augments coelomocyte phagocytosis in bacteria-challenged Apostichopus japonicus via targeting the TLR component of IRAK-1 in vitro and in vivo.

Authors:  Meng Lu; Peng-Juan Zhang; Cheng-Hua Li; Zhi-Meng Lv; Wei-Wei Zhang; Chun-Hua Jin
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

10.  Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes.

Authors:  Shali Chen; Prasanth Puthanveetil; Biao Feng; Scot J Matkovich; Gerald W Dorn; Subrata Chakrabarti
Journal:  J Cell Mol Med       Date:  2014-01-16       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.